Deciphera Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) announced that Steve Hoerter, President and CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024. The live webcast will be available on the company's website.

WALTHAM, Mass.--(BUSINESS WIRE)-- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that Steve Hoerter, President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 4:30 PM PT / 7:30 PM ET.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/events-presentations. A replay will be archived on the Company’s website for 30 days following the presentation.

About Deciphera Pharmaceuticals

Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s switch-control inhibitor for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Israel, Macau, New Zealand, Singapore, Switzerland, Taiwan, the United Kingdom, and the United States. For more information, visit www.deciphera.com and follow us on LinkedIn and X (@Deciphera).

View source version on businesswire.com: https://www.businesswire.com/news/home/20240102600227/en/

Investor Relations:

Maghan Meyers

Argot Partners

Deciphera@argotpartners.com

212-600-1902

Media:

David Rosen

Argot Partners

david.rosen@argotpartners.com

212-600-1902

Source: Deciphera Pharmaceuticals, Inc.

FAQ

When is the 42nd Annual J.P. Morgan Healthcare Conference?

The conference is on January 9, 2024.

Who will present at the conference?

Steve Hoerter, President and CEO of Deciphera Pharmaceuticals, Inc.

Where can I watch the live webcast of the event?

The live webcast will be available on the 'Events and Presentations' page in the 'Investors' section of the Company’s website at https://investors.deciphera.com/events-presentations.

How long will the replay be available on the Company's website?

The replay will be archived on the Company’s website for 30 days following the presentation.